When organizations prioritize a clear purpose over profit, they have a positive influence on consumers and stakeholders of ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Management targets JPY 65 billion-JPY 75 billion in capital expenditure per year over the medium term. We think its operating cash flow could support such a level of investments, but the dividend ...

Q4 2024 Earnings Call Transcript February 13, 2025 Global Payments Inc. misses on earnings expectations. Reported EPS is ...

TE Connectivity, the global leader in sensor and connectivity technologies, has acquired Richards Manufacturing, strengthening its industrial positioning ...